BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23276828)

  • 1. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery.
    Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
    Nucl Med Commun; 2013 Mar; 34(3):249-53. PubMed ID: 23276828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
    Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
    J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas.
    Meewes C; Bohuslavizki KH; Krisch B; Held-Feindt J; Henze E; Clausen M
    J Nucl Med; 2001 Sep; 42(9):1338-45. PubMed ID: 11535722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas.
    Gay E; Vuillez JP; Palombi O; Brard PY; Bessou P; Passagia JG
    Neurosurgery; 2005 Jul; 57(1 Suppl):107-13; discussion 107-13. PubMed ID: 15987576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma.
    Hellwig D; Samnick S; Reif J; Romeike BF; Reith W; Moringlane JR; Kirsch CM
    Clin Nucl Med; 2002 Nov; 27(11):781-4. PubMed ID: 12394124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
    Trogrlic M; Tezak S
    Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of combined diagnostic CT and (99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on pulmonary nodule characterization in patients.
    Wang L; Yin X; Wang F; Gu J; Lu L; Wu Q; Shen B; Li XF
    Cancer Biother Radiopharm; 2013 Dec; 28(10):731-6. PubMed ID: 24094076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma.
    Klutmann S; Bohuslavizki KH; Brenner W; Behnke A; Tietje N; Kröger S; Hugo HH; Mehdorn HM; Clausen M; Henze E
    J Nucl Med; 1998 Nov; 39(11):1913-7. PubMed ID: 9829583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma.
    Klutmann S; Bohuslavizki KH; Tietje N; Kröger S; Behnke A; Brenner W; Mester J; Henze E; Clausen M
    J Nucl Med; 1999 Aug; 40(8):1246-51. PubMed ID: 10450673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
    Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
    Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
    Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of
    Trogrlic M; Težak S
    Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
    Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
    J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma knife radiosurgery in skull base meningiomas: a possible relationship between somatostatin receptor decrease and early neurological improvement without tumour shrinkage at short-term imaging follow-up.
    Nicolato A; Giorgetti P; Foroni R; Grigolato D; Pasquin IP; Zuffante M; Soda C; Tomassini A; Gerosa M
    Acta Neurochir (Wien); 2005 Apr; 147(4):367-74; discussion 374-5. PubMed ID: 15696264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
    Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
    Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.